Amgen (AMGN) Total Debt (2009 - 2026)

Amgen has reported Total Debt for 18 years, with the latest figure at $62.7 billion in Q2 2026.

• On a quarterly basis, Total Debt rose 6.99% year-over-year to $62.7 billion in Q2 2026; TTM through Jun 2026 was $62.7 billion, a 6.99% increase from a year earlier, with the FY2025 full-year figure at $59.2 billion, down 6.99% from the prior year.
• Total Debt was $62.7 billion for Q2 2026 at Amgen, roughly flat from $62.8 billion in the prior quarter.
• The five-year high for Total Debt was $68.2 billion in Q2 2024, with the low at $37.3 billion in Q2 2022.
• Average Total Debt over 5 years is $57.5 billion, with a median of $62.2 billion recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Total Debt jumped 70.63% in 2023, then declined 13.97% in 2025.
• Over 5 years, Total Debt stood at $40.5 billion in 2022, then jumped by 62.96% to $66.1 billion in 2023, then decreased by 3.64% to $63.6 billion in 2024, then fell by 6.99% to $59.2 billion in 2025, then rose by 5.99% to $62.7 billion in 2026.
• The last three Total Debt figures came in at $62.7 billion (Q2 2026), $62.8 billion (Q1 2026), and $59.2 billion (Q4 2025), per Business Quant data.